tradingkey.logo
tradingkey.logo

Nektar Therapeutics Receives Fast Track Designation For Rezpegaldesleukin For The Treatment Of Severe-To-Very Severe Alopecia Areata

ReutersJul 29, 2025 2:18 PM

- Nektar Therapeutics NKTR.O:

  • NEKTAR THERAPEUTICS RECEIVES FAST TRACK DESIGNATION FOR REZPEGALDESLEUKIN FOR THE TREATMENT OF SEVERE-TO-VERY SEVERE ALOPECIA AREATA

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI